The Food and Drug Administration (FDA) has reportedly approved the use by Ohio State University (OSU) investigators of brain pacemakers as an obesity treatment. Deep-brain stimulation has apparently been approved for use in the treatment of disorders such as Parkinson’s disease, tremor, dystonia, and severe obsessive-compulsive disorder, and OSU researchers and clinicians evidently made the case for use of the therapy to treat obesity in an article recently published in Neurosurgery. According to OSU Professor of Neurological Surgery Ali Rezai, the goal will be to stimulate the region of the brain linked to addictive behavior to improve its function, regulation and control. “Research shows that many of the complexities of obesity are traced to faulty signals in the brain. Considering the heightened health risks in obese individuals and the problems that some patients have after bariatric surgery, it is reasonable to consider deep-brain stimulation as a treatment,” he said. See, August 27, 2012.